Xu Stella Insider Trades

Insider Trading History

Track insider trading activity for Xu Stella. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Design Therapeutics
Design Therapeutics DSGN
Director
Holding Value $161k 15,000 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.5k 15,000 shares
$5.63
$10.76
Design Therapeutics
Design Therapeutics DSGN
Director
Holding Value $161k 15,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 15,000 shares
$13.69
$10.76
Design Therapeutics
Design Therapeutics DSGN
Director
Holding Value $44.7M 4,155,405 shares
Last Trade
Mar 18, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$268k 13,200 shares
$20.34
$10.76
Tempest Therapeutics
Tempest Therapeutics TPST
Director
Holding Value $8.63k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.4k 6,635 shares
$11.07
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $7.03k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.03k 6,635 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $8.63k 6,635 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.4k 6,635 shares
$11.07
$1.30
Millendo Therapeutics
Millendo Therapeutics MLND
Director
Holding Value $614k 579,710 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$614k 579,710 shares
$1.06
$1.06
Tempest Therapeutics
Tempest Therapeutics TPST
Holding Value $754k 579,710 shares
Last Trade
Jun 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.22M 579,710 shares
$15.90
$1.30
Nextcure
Nextcure NXTC
Director
Holding Value $45.5k 14,250 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 14,250 shares
$98.52
$3.19
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $0 0 shares
Last Trade
Mar 30, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$227M 7,694,954 shares
$29.52
$10.76
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $50.8M 4,720,830 shares
Last Trade
Mar 30, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$139M 4,720,830 shares
$29.52
$10.76
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $50.9M 4,730,830 shares
Last Trade
Mar 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$295k 10,000 shares
$29.52
$10.76
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $161k 15,000 shares
Last Trade
Mar 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$10.76
Design Therapeutics
Design Therapeutics DSGN
10% owner
Holding Value $0 0 shares
Last Trade
Mar 25, 2021 Sale
No data
No data
$10.76
Nextcure
Nextcure NXTC
Director
Holding Value $45.5k 14,250 shares
Last Trade
Jun 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.13M 14,250 shares
$289.56
$3.19
Nextcure
Nextcure NXTC
Director
Holding Value $70.2k 22,000 shares
Last Trade
Jun 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.11M 22,000 shares
$186.84
$3.19
Nextcure
Nextcure NXTC
Director
Holding Value $0 0 shares
Last Trade
May 13, 2019 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.83B 7,861,636 shares
$232.80
$3.19
Nextcure
Nextcure NXTC
Director
Holding Value $3.12M 978,570 shares
Last Trade
May 13, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$228M 978,570 shares
$232.80
$3.19
Nextcure
Nextcure NXTC
Director
Holding Value $3.52M 1,103,570 shares
Last Trade
May 13, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$29.1M 125,000 shares
$232.80
$3.19
Nextcure
Nextcure NXTC
10% owner
Holding Value $0 0 shares
Last Trade
May 08, 2019 Sale
No data
No data
$3.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up